Cargando…

Subtype switching in breast cancer brain metastases: a multicenter analysis

BACKGROUND: Breast cancer (BC) brain metastases (BM) can have discordant hormonal or human epidermal growth factor receptor 2 (HER2) expression compared with corresponding primary tumors. This study aimed to describe incidence, predictors, and survival outcomes of discordant receptors and associated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hulsbergen, Alexander F C, Claes, An, Kavouridis, Vasileios K, Ansaripour, Ali, Nogarede, Claudine, Hughes, Melissa E, Smith, Timothy R, Brastianos, Priscilla K, Verhoeff, Joost J C, Lin, Nancy U, Broekman, Marike L D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Clinical Investigations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471502/ https://www.ncbi.nlm.nih.gov/pubmed/31970416 http://dx.doi.org/10.1093/neuonc/noaa013

Ejemplares similares

75. PROGRAMMED DEATH RECEPTOR LIGAND ONE EXPRESSION MAY INDEPENDENTLY PREDICT SURVIVAL IN NON-SMALL CELL LUNG CARCINOMA BRAIN METASTASES PATIENTS RECEIVING IMMUNOTHERAPY
por: Hulsbergen, Alexander, et al.
Publicado: (2020)

Age, pathology and CA-125 are prognostic factors for survival in patients with brain metastases from gynaecological tumours
por: Nagtegaal, S.H.J., et al.
Publicado: (2020)

Systemic therapy following craniotomy in patients with a solitary breast cancer brain metastasis
por: Hulsbergen, Alexander F. C., et al.
Publicado: (2020)

74. EFFICACY OF HER2-TARGETED THERAPY IN HER2-POSITIVE BREAST CANCER BRAIN METASTASES: A NATIONAL ANALYSIS
por: Hulsbergen, Alexander, et al.
Publicado: (2020)

Fibrinolytics and Intraventricular Hemorrhage: A Systematic Review and Meta-analysis
por: van Solinge, Thomas S., et al.
Publicado: (2019)

Genetic Characterization of Brain Metastases in the Era of Targeted Therapy
por: Han, Catherine H., et al.
Publicado: (2017)

72. THE COMBINED USE OF STEROIDS AND IMMUNE CHECKPOINT INHIBITORS IN BRAIN METASTASES PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Jessurun, Charissa, et al.
Publicado: (2020)

73. PREDICTION OF A SECOND LOCAL RECURRENCE IN SURGICALLY TREATED RECURRENT BRAIN METASTASES PATIENTS
por: Tewarie, Ishaan, et al.
Publicado: (2020)

OTHR-04. INCIDENCE AND SURVIVAL OUTCOMES IN UROTHELIAL CARCINOMA BRAIN METASTASES
por: Kavouridis, Vasileios, et al.
Publicado: (2019)

Precision medicine biomarkers in brain metastases: applications, discordances, and obstacles
por: Steindl, Ariane, et al.
Publicado: (2021)

Leptomeningeal disease in neurosurgical brain metastases patients: A systematic review and meta-analysis
por: Tewarie, Ishaan Ashwini, et al.
Publicado: (2021)

OTHR-10. THE NATIONAL DISTRIBUTION OF NEWLY-DIAGNOSED BRAIN METASTASES IN ADULTS VARIES WIDELY BY PATIENT DEMOGRAPHICS
por: Kavouridis, Vasileios, et al.
Publicado: (2019)

Leptomeningeal Metastases from Solid Tumors: Recent Advances in Diagnosis and Molecular Approaches
por: Pellerino, Alessia, et al.
Publicado: (2021)

Management of hydrocephalus in patients with leptomeningeal metastases: an ethical approach to decision-making
por: Lamba, Nayan, et al.
Publicado: (2018)

Special issue: advances in the multimodality management of brain metastases and ongoing approaches to further improve their treatment
por: Zuccato, Jeffrey A, et al.
Publicado: (2021)

MLTI-16. SYSTEMIC THERAPY FOLLOWING CRANIOTOMY IN PATIENTS WITH A SOLITARY BREAST CANCER BRAIN METASTASIS
por: Hulsbergen, Alexander, et al.
Publicado: (2019)

67. INCREASED RISK OF BREAST CANCER BRAIN METASTASIS WITH EGFR AND Ki-67 EXPRESSION: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Job, Arun, et al.
Publicado: (2020)

Oversight in Surgical Innovation: A Response to Ethical Challenges
por: Gupta, Saksham, et al.
Publicado: (2018)

Beta-blockers and glioma: a systematic review of preclinical studies and clinical results
por: Tewarie, Ishaan Ashwini, et al.
Publicado: (2020)

Efficacy of stereotactic ablative radiotherapy (SABR) during anti-PD-1 in oligoprogressive non-small cell lung cancer and melanoma—a prospective multicenter observational study pointing out new unmet needs
por: Damen, Pim J. J., et al.
Publicado: (2023)

Tolerability of BRAF and MEK Inhibitors for Metastasized Melanoma after Intra-Class Switch: A Multicenter, Retrospective Study
por: Salzmann, Martin, et al.
Publicado: (2023)

The effect of smoking on survival in lung carcinoma patients with brain metastasis: a systematic review and meta-analysis
por: Chawla, Shreya, et al.
Publicado: (2022)

SPCR-07 REDEFINING BOUNDARIES: STEREOTACTIC RADIOSURGERY FOR ENHANCED QUALITY OF LIFE AND SURVIVAL IN PATIENTS WITH 5-20 BRAIN METASTASES
por: Cialdella, Fia, et al.
Publicado: (2023)

TIPS-16 A PROSPECTIVE COHORT STUDY ON THE IMPACT OF RADIOTHERAPY ON QUALITY OF LIFE AND DISEASE PROGRESSION IN PATIENTS WITH BRAIN METASTASES AND THEIR CAREGIVERS
por: Cialdella, Fia, et al.
Publicado: (2023)

Evidence-based dexamethasone dosing in malignant brain tumors: what do we really know?
por: Jessurun, Charissa A. C., et al.
Publicado: (2019)

Stereotactic radiosurgery versus whole-brain radiotherapy after intracranial metastasis resection: a systematic review and meta-analysis
por: Lamba, Nayan, et al.
Publicado: (2017)

Apparent diffusion coefficient cannot predict molecular subtype and lymph node metastases in invasive breast cancer: a multicenter analysis
por: Surov, Alexey, et al.
Publicado: (2019)

Assessment of Effectiveness and Safety of Osimertinib for Patients With Intracranial Metastatic Disease: A Systematic Review and Meta-analysis
por: Erickson, Anders W., et al.
Publicado: (2020)

A Dutch phase III randomized multicenter trial: whole brain radiotherapy versus stereotactic radiotherapy for 4–10 brain metastases
por: Hartgerink, Dianne, et al.
Publicado: (2021)

Defensive medicine among neurosurgeons in the Netherlands: a national survey
por: Yan, Sandra C., et al.
Publicado: (2017)

Clinicogenomic factors and treatment patterns among patients with advanced non–small cell lung cancer with or without brain metastases in the United States
por: Smyth, Emily Nash, et al.
Publicado: (2023)

Clinical utility of convolutional neural networks for treatment planning in radiotherapy for spinal metastases
por: Arends, Sebastiaan R.S., et al.
Publicado: (2022)

Global comparison of awake and asleep mapping procedures in glioma surgery: An international multicenter survey
por: Gerritsen, Jasper K W, et al.
Publicado: (2022)

Targeting Molecular Pathways in Intracranial Metastatic Disease
por: Venur, Vyshak Alva, et al.
Publicado: (2019)

Brain metastases free survival differs between breast cancer subtypes
por: Berghoff, A, et al.
Publicado: (2012)

Editorial. Task shifting and task sharing for neurosurgeons amidst the COVID-19 pandemic
por: Robertson, Faith C., et al.
Publicado: (2020)

04. ASSESSMENT OF EFFICACY AND SAFETY OF OSIMERTINIB FOR PATIENTS WITH INTRACRANIAL METASTATIC DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Erickson, Anders, et al.
Publicado: (2020)

Emerging systemic treatment options in meningioma
por: Mair, Maximilian J., et al.
Publicado: (2022)

The history of head transplantation: a review
por: Lamba, Nayan, et al.
Publicado: (2016)

Basic science in neurosurgery
por: van Solinge, Thomas S., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bntbsj9qv7a4f9uhfs0o1fqqo2